Please use this identifier to cite or link to this item:
https://islhd.intersearch.com.au/islhdjspui/handle/1/6197
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Conley J | en |
dc.contributor.author | Perry JR | en |
dc.contributor.author | Ashford B | en |
dc.contributor.author | Ranson M | en |
dc.date.accessioned | 2024-05-01T03:26:07Z | - |
dc.date.available | 2024-05-01T03:26:07Z | - |
dc.date.issued | 2024-04-01 | - |
dc.identifier.citation | Exp Dermatol. 2024 Apr;33(4):e15089. doi: 10.1111/exd.15089. | en |
dc.identifier.uri | https://islhd.intersearch.com.au/islhdjspui/handle/1/6197 | - |
dc.subject | Squamous Cell Carcinoma | - |
dc.title | Ex vivo therapeutic screening of metastatic cSCC: A review of methodological considerations for clinical implementation | en |
dc.identifier.journaltitle | Exp Dermatol | en |
dc.identifier.doi | 10.1111/exd.15089 | en |
dc.contributor.islhd | Ashford, Bruce | en |
Appears in Collections: | Research publications from current and former ISLHD staff. |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.